ProCE Banner Activity

How New Data From CROI 2017 May Inform Treatment Simplification Options

Clinical Thought
Is the switch to a 2-drug regimen in virologically suppressed HIV-infected patients feasible?

Released: April 20, 2017

Expiration: April 19, 2018

No longer available for credit.

Share

Faculty

Charles B. Hicks

Charles B. Hicks, MD

Professor of Medicine
Duke University Medical Center
Durham, North Carolina

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

ViiV Healthcare

Faculty Disclosure

Primary Author

Charles B. Hicks, MD

Professor of Medicine
Duke University Medical Center
Durham, North Carolina

Charles B. Hicks, MD, has disclosed that he has received consulting fees from Janssen, Merck, and ViiV and royalties from UpToDate, Inc.